These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18774574)

  • 1. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.
    Hulkkonen J; Lehtimäki T; Mononen N; Juonala M; Hutri-Kähönen N; Taittonen L; Marniemi J; Nieminen T; Viikari J; Raitakari O; Kähönen M
    Atherosclerosis; 2009 Apr; 203(2):454-8. PubMed ID: 18774574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.
    Riikola A; Sipilä K; Kähönen M; Jula A; Nieminen MS; Moilanen L; Kesäniemi YA; Lehtimäki T; Hulkkonen J
    Atherosclerosis; 2009 Dec; 207(2):466-70. PubMed ID: 19592000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the IL10 promoter region and early markers of atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Heiskanen M; Kähönen M; Hurme M; Lehtimäki T; Mononen N; Juonala M; Hutri-Kähönen N; Viikari J; Raitakari O; Hulkkonen J
    Atherosclerosis; 2010 Jan; 208(1):190-6. PubMed ID: 19700159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
    Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
    Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.
    Orbe J; Beloqui O; Rodriguez JA; Belzunce MS; Roncal C; Páramo JA
    Clin Chim Acta; 2006 Jun; 368(1-2):138-43. PubMed ID: 16458279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis.
    Palomino-Morales R; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J; Martin J; Gonzalez-Gay MA
    Clin Exp Rheumatol; 2009; 27(6):964-70. PubMed ID: 20149313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study.
    Hernesniemi JA; Heikkilä A; Raitakari OT; Kähönen M; Juonala M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
    Ann Med; 2010 Apr; 42(3):223-30. PubMed ID: 20350254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Fan YM; Raitakari OT; Kähönen M; Hutri-Kähönen N; Juonala M; Marniemi J; Viikari J; Lehtimäki T
    Clin Genet; 2009 Jul; 76(1):46-53. PubMed ID: 19558527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6.
    Tischendorf JJ; Yagmur E; Scholten D; Vidacek D; Koch A; Winograd R; Gressner AM; Trautwein C; Wasmuth HE; Lammert F
    Int J Immunogenet; 2007 Dec; 34(6):413-8. PubMed ID: 18001296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
    Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism - The Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Mansikkaniemi K; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari JS; Lehtimäki TJ
    Clin Chem Lab Med; 2008; 46(8):1102-8. PubMed ID: 18605953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.
    Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A
    Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population.
    You CG; Li XJ; Li YM; Wang LP; Li FF; Guo XL; Gao LN
    Cytokine; 2013 Jan; 61(1):133-8. PubMed ID: 23148991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors.
    Lieb W; Pavlik R; Erdmann J; Mayer B; Holmer SR; Fischer M; Baessler A; Hengstenberg C; Loewel H; Doering A; Riegger GA; Schunkert H
    Int J Cardiol; 2004 Nov; 97(2):205-12. PubMed ID: 15458685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of polymorphisms G(-174)C in IL-6 gene and G(-1082)A in IL-10 gene with traditional cardiovascular risk factors in patients with coronary artery disease.
    Elsaid A; Abdel-Aziz AF; Elmougy R; Elwaseef AM
    Indian J Biochem Biophys; 2014 Aug; 51(4):282-92. PubMed ID: 25296499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.
    Sung KC; Wild SH; Byrne CD
    Atherosclerosis; 2013 Dec; 231(2):181-6. PubMed ID: 24267222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
    Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
    Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
    Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C; Cam FS; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
    Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.